EU To Consider Concessions In Pfizer, Wyeth Review
The European Commission has extended the deadline for its review of Pfizer Inc.'s proposed $68 billion acquisition of Wyeth Inc. because Pfizer offered the regulator commitments related to the companies' animal...To view the full article, register now.
Already a subscriber? Click here to view full article